Funded Tech Companies
Eyevensys
Wondering who provided funding to Eyevensys? Boehringer Ingelheim Venture Fund, Pontifax Fund and BB Pureos Bioventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Eyevensys
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
11 rue Watt -- Bat B
Paris, 75013
France
Paris, 75013
France
Phone
Website
Email Address
Company Background Information
Overview
Eyevensys is dedicated to the research and development of innovative therapies for the treatment of ocular diseases by non viral gene therapy. Eyevensys S.A.S. is a privately held biotechnology company developing a game changing approach to express therapeutic proteins in situ for the treatment of major ophthalmic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/9/2020
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patricia Zilliox
Chief Medical Officer
Ronald Buggage
Chief Scientific Officer
Francine Behar-Cohen
Company Investors
- Boehringer Ingelheim Venture Fund
- Pontifax Fund (Ohad Hammer)
- BB Pureos Bioventures
- CapDecisif
- Bpifrance
- Global Health Sciences Fund
- Inserm Transfert Initiative
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs